About DrFirst
DrFirst is a company based in Rockville (United States) founded in 2000 by James F Chen. DrFirst has raised $85.8 million across 8 funding rounds from investors including SVB, SunTrust Bank and Sixth Street. DrFirst has completed 3 acquisitions, including Myndshft, The IN Group and VisibilityRx. DrFirst offers products and services including E-Prescribing, Electronic Prior Authorization, Medication History, and Patient Engagement. DrFirst operates in a competitive market with competitors including Azalea Health, Innovaccer, Health Catalyst, CitiusTech and CompuGroup Medical, among others.
- Headquarter Rockville, United States
- Founders James F Chen
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Drfirst.Com, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DrFirst
DrFirst offers a comprehensive portfolio of products and services, including E-Prescribing, Electronic Prior Authorization, Medication History, and Patient Engagement.
Facilitates electronic prescribing to ease staff burden and meet regulations.
Automates access to specialty drugs for faster approvals.
Provides complete medication data via a large U.S. network.
Delivers personalized messages for education and reminders.
People of DrFirst
Unlock access to complete
Unlock access to complete
Leadership Team
28 people
Software Development Team
23 people
Sales and Marketing
16 people
Product Management Team
12 people
Operations Team
10 people
Data Analysis and Operations Team
8 people
Senior Team
5 people
Human Resources and Administration
3 people
Unlock access to complete
Funding Insights of DrFirst
DrFirst has successfully raised a total of $85.8M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DrFirst
DrFirst has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, SunTrust Bank and Sixth Street.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and debt investments are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Liquidity solutions are provided to private shareholders and companies.
|
Locked | Locked | Locked | |
|
Commercial banking services are offered to individuals and businesses.
|
Locked | Locked | Locked |
Investor details for DrFirst
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DrFirst
DrFirst has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Myndshft, The IN Group and VisibilityRx.
Investment portfolio details for DrFirst
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of financial benefits and prior authorization management platform
|
Locked | Locked | 2015 | Locked | |
|
Solutions for patient identification, recruitment and communication for clinical research, risk evaluation and mitigation and market research
|
Locked | Locked | 2010 | Locked | |
|
Patient engagement, medical benefits, and medication management services are offered.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for DrFirst
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - DrFirst
Detailed financials for DrFirst
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Drfirst Comparisons
Peer comparison for DrFirst
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DrFirst
DrFirst operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Azalea Health, Innovaccer, Health Catalyst, CitiusTech and CompuGroup Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
EHR Platform with integrated Telehealth, Mobile health and RCM solutions for healthcare providers
|
|
| Locked | Locked | Locked |
Provider of an AI-powered cloud platform for healthcare performance improvement
|
|
| Locked | Locked | Locked |
Cloud-based data analytics are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Provider of AI solutions for clinical, operational, and business outcomes
|
|
| Locked | Locked | Locked |
Suite of practice management, reimbursement, laboratory and analytics solutions to healthcare providers
|
Detailed competitors of DrFirst
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Drfirst
Complete news archive for DrFirst
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DrFirst
DrFirst was founded in 2000 and raised its 1st funding round 2 years after it was founded.
DrFirst is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
G Cameron Deemer is the current CEO of DrFirst.
DrFirst is a funded company, having raised a total of $85.8M across 8 funding rounds to date.
DrFirst was founded in 2000 and is headquartered in Rockville, United States. Software solutions are provided for e-prescription and secure messaging within the healthcare sector. Practice management and administrative tasks are supported through developed tools. Patient engagement, medication management, and care coordination features are incorporated to assist providers in operational needs.
DrFirst's top competitors include Innovaccer, CompuGroup Medical and CitiusTech.
DrFirst offers E-Prescribing, Electronic Prior Authorization, Medication History, and Patient Engagement.
DrFirst has made 3 acquisitions, including Myndshft, The IN Group, and VisibilityRx.
DrFirst has 5 investors. Key investors include SVB, SunTrust Bank, Sixth Street, Goldman Sachs Investment Partners, and Savano Capital Partners.